CRE25-040: A Case of Stage IV NSCLC With MET Exon 14 Mutation With Durable Response to MET Inhibitor Following Cessation of Therapy Due to Toxicity: Insights for Treatment Strategies
Year: 2025
Type: article
Study design: Case Report
Authors: Chanmi Lee, Emmeline Academia, Page C. Widick
Institution: Beth Israel Deaconess Medical Center
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4408953241